Diabetic nephropathy: A frontier for personalized medicine

Journal of the American Society of Nephrology

Volumn 17, Issue 2, 2006, Pages 361-367

  Susztak, Katalin ^a   Böttinger, Erwin P ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; MESSENGER RNA; MOLECULAR MARKER;

ALBUMINURIA; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE EXPRESSION PROFILING; GENE LOCUS; GENE TARGETING; GENETIC SCREENING; GENETIC VARIABILITY; GLOMERULUS FILTRATION; HEREDITY; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RELIABILITY; REVIEW; URINARY EXCRETION; VALIDATION PROCESS;

EID: 33645460906     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005101109     Document Type: Review

References (48)

1. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D, Grimm R, Liu J, Louis T, Manning W, Matas A, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li S, Li S, Roberts T, Snyder J, Solid C, Wang C, Weinhandl E, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Johnson R, Sheets D, Forrest B, Berrini D, Constantini E, Everson S, Frederick P, Eggers P, Agodoa L: Excerpts from the United States Renal Data System 2004 annual data report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 45: A5-A7, 2005
2. Iyengar SK, Schelling JR, Sedor JR: Approaches to understanding susceptibility to nephropathy: From genetics to genomics. Kidney Int 61: 61-67, 2002
3. Caramori ML, Mauer M: Diabetes and nephropathy. Curr Opin Nephrol Hypertens 12: 273-282, 2003
4. Ng DP, Krolewski AS: Molecular genetic approaches for studying the etiology of diabetic nephropathy. Curr Mol Med 5: 509-525, 2005
5. Ritz E: Managing anaemia and diabetes: A future challenge for nephrologists. Nephrol Dial Transplant 20[Suppl 6]: vi21-25, 2005
6. Jones CA, Krolewski AS, Rogus J, Xue JL, Collins A, Warram JH: Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause? Kidney Int 67: 1684-1691, 2005
7. Parving HH: Diabetic nephropathy: Prevention and treatment. Kidney Int 60: 2041-2055, 2001
8. Colwell JA: Intensive insulin therapy in type II diabetes: Rationale and collaborative clinical trial results. Diabetes 45[Suppl 3]: S87-S90, 1996
9. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 342: 381-389, 2000
10. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165, 1989
11. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869, 2001
12. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851-860, 2001
13. Meyer TW, Bennett PH, Nelson RG: Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia 42: 1341-1344, 1999
14. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99: 342-348, 1997
15. Steffes MW, Schmidt D, McCrery R, Basgen JM: Glomerular cell number in normal subjects and in type I diabetic patients. Kidney Int 59: 2104-2113, 2001
16. Klein JB, Thongboonkerd V: Overview of proteomics. Contrib Nephrol 141: 1-10, 2004
17. Thongboonkerd V, Barati MT, McLeish KR, Pierce WM, Epstein PN, Klein JB: Proteomics and diabetic nephropathy. Contrib Nephrol 141: 142-154, 2004
18. Thongboonkerd V, Malasit P: Renal and urinary proteomics: Current applications and challenges. Proteomics 5: 1033-1042, 2005
19. Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P: Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 65: 323-332, 2004
20. Rossing K, Mischak H, Parving HH, Christensen PK, Walden M, Hillmann M, Kaiser T: Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. Kidney Int 68: 193-205, 2005
21. Mischak H, Kaiser T, Walden M, Hillmann M, Wittke S, Herrmann A, Knueppel S, Haller H, Fliser D: Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond) 107: 485-495, 2004
22. Sharma K, Lee S, Han S, Lee S, Francos B, McCue P, Wassell R, Shaw MA, RamachandraRao SP: Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 5: 2648-2655, 2005
23. Ferea TL, Brown PO: Observing the living genome. Curr Opin Genet Dev 9: 715-722, 1999
24. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL: Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14: 1675-1680, 1996
25. Susztak K, Sharma K, Schiffer M, McCue P, Ciccone E, Bottinger EP: Genomic strategies for diabetic nephropathy. J Am Soc Nephrol 14[Suppl]: S271-278, 2003
26. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ: High density synthetic oligonucleotide arrays. Nat Genet 21: 20-24, 1999
27. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470, 1995
28. van Steensel B: Mapping of genetic and epigenetic regulatory networks using microarrays. Nat Genet 37[Suppl]: S18-S24, 2005
29. Stoughton RB: Applications of DNA microarrays in biology. Annu Rev Biochem 74: 53-82, 2005
30. Bottinger EP, Ju W, Zavadil J: Applications for microarrays in renal biology and medicine. Exp Nephrol 10: 93-101, 2002
31. Liang M, Cowley AW Jr, Hessner MJ, Lazar J, Basile DP, Pietrusz JL: Transcriptome analysis and kidney research: Toward systems biology. Kidney Int 67: 2114-2122, 2005
32. Kretzler M, Cohen CD, Doran P, Henger A, Madden S, Grone EF, Nelson PJ, Schlondorff D, Grone HJ: Repuncturing the renal biopsy: Strategies for molecular diagnosis in nephrology. J Am Soc Nephrol 13: 1961-1972, 2002
33. Cohen CD, Frach K, Schlondorff D, Kretzler M: Quantitative gene expression analysis in renal biopsies: A novel protocol for a high-throughput multicenter application. Kidney Int 61: 133-140, 2002
34. Peterson KS, Huang JF, Zhu J, D'Agati V, Liu X, Miller N, Erlander MG, Jackson MR, Winchester RJ: Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 113: 1722-1733, 2004
35. Churchill GA: Fundamentals of experimental design for cDNA microarrays. Nat Genet 32[Suppl]: 490-495, 2002
36. Quackenbush J: Computational analysis of microarray data. Nat Rev Genet 2: 418-427, 2001
37. Stoeckert CJ Jr, Causton HC, Ball CA: Microarray databases: Standards and ontologies. Nat Genet 32[Suppl]: 469-473, 2002
38. Slonim DK: From patterns to pathways: Gene expression data analysis comes of age. Nat Genet 32[Suppl]: 502-508, 2002
39. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286: 531-537, 1999
40. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, Lander ES, Golub TR: Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 98: 15149-15154, 2001
41. Chuaqui RF, Bonner RF, Best CJ, Gillespie JW, Flaig MJ, Hewitt SM, Phillips JL, Krizman DB, Tangrea MA, Ahram M, Linehan WM, Knezevic V, Emmert-Buck MR: Post-analysis follow-up and validation of microarray experiments. Nat Genet 32[Suppl]: 509-514, 2002
42. Baelde HJ, Eikmans M, Doran PP, Lappin DW, de Heer E, Bruijn JA: Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 43: 636-650, 2004
43. Wada J, Zhang H, Tsuchiyama Y, Hiragushi K, Hida K, Shikata K, Kanwar YS, Makino H: Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis. Kidney Int 59: 1363-1373, 2001
44. Mishra R, Emancipator SN, Miller C, Kern T, Simonson MS: Adipose differentiation-related protein and regulators of lipid homeostasis identified by gene expression profiling in the murine db/db diabetic kidney. Am J Physiol Renal Physiol 286: F913-F921, 2004
45. Wilson KH, Eckenrode SE, Li QZ, Ruan QG, Yang P, Shi JD, Davoodi-Semiromi A, McIndoe RA, Croker BP, She JX: Microarray analysis of gene expression in the kidneys of new- and post-onset diabetic NOD mice. Diabetes 52: 2151-2159, 2003
46. Fan Q, Shike T, Shigihara T, Tanimoto M, Gohda T, Makita Y, Wang LN, Horikoshi S, Tomino Y: Gene expression profile in diabetic KK/Ta mice. Kidney Int 64: 1978-1985, 2003
47. Susztak K, Bottinger E, Novetsky A, Liang D, Zhu Y, Ciccone E, Wu D, Dunn S, McCue P, Sharma K: Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 53: 784-794, 2004
48. Susztak K, Ciccone E, McCue P, Sharma K, Bottinger EP: Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med 2: e45, 2005